IP Library Assignment 023039/0017
Patent Assignment
Reel/Frame 023039/0017

Assignment of Assignor's Interest

Recorded: 2009-07-31 Pages: 35
Assignor
NAUTILUS BIOTECH S.A.
Executed: 2009-06-10
Assignee
HANALL PHARMACEUTICAL CO., LTD.
400-1, SANGSEO-DONG, DAEDEOK-GU,, DAEJEON 306-120, KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF
Covered Property (1)
High Throughput Directed Evolution by Rational Mutagenesis
Patent: 7,647,184 →
Application: 10/022,249 →
Publication: US 2003/0134351
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 22, 2002
From: VEGA, MANUEL; DRITTANTI, LILA
To: NAUTILUS BIOTECH S.A.
Reel/Frame 013130/0131 →
Corrective Assignment to Correct the Assignee's Country Previously Recorded on Reel 023039 Frame 0017. Assignor(S) Hereby Confirms the Assignee's Country Is: the Republic of Korea (South Korea). Sep 10, 2009
From: NAUTILUS BIOTECH S.A.
To: HANALL PHARMACEUTICAL CO., LTD.
Reel/Frame 023216/0342 →
Change of Name May 13, 2010
From: HANALL PHARMACEUTICAL CO., LTD.
To: HANALL BIOPHARMA CO., LTD.
Reel/Frame 024380/0158 →